Last reviewed · How we verify
Continuous IV remifentanil
At a glance
| Generic name | Continuous IV remifentanil |
|---|---|
| Also known as | IVR |
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Continuous IV remifentanil CI brief — competitive landscape report
- Continuous IV remifentanil updates RSS · CI watch RSS
- Tel-Aviv Sourasky Medical Center portfolio CI